PAB8943

antibody from Abnova Corporation

Targeting: CXCR3 CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR

Western blot (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Antibody Data

Product number

PAB8943

Provider

Abnova Corporation

Proper citation

Abnova Corporation Cat#PAB8943, RRID:AB_1672578

Product name

Cxcr3 polyclonal antibody

Antibody type

Polyclonal

Antigen

A synthetic peptide corresponding to amino acids 24-42 of rat/mouse Cxcr3.

Host

Rabbit

Antigen sequence

PYDYGENESDFSDSPPC


Vial size

100 µg

Storage

Store at -20°C.Aliquot to avoid repeated freezing and thawing.

References

Submitted references

Activation of CXCL10/CXCR3 signaling attenuates morphine analgesia: involvement of Gi protein.

Ye D, Bu H, Guo G, Shu B, Wang W, Guan X, Yang H, Tian X, Xiang H, Gao F
Journal of molecular neuroscience : MN 2014 Aug;53(4):571-9

---

Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes.

Kanda N, Hau CS, Tada Y, Tatsuta A, Sato S, Watanabe S
Endocrinology 2011 Aug;152(8):3155-64

---

The role of chemokines and chemokine receptors in progressive renal diseases.

Segerer S
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003 Mar;41(3 Suppl 1):S15-8

---

Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation.

Xie JH, Nomura N, Lu M, Chen SL, Koch GE, Weng Y, Rosa R, Di Salvo J, Mudgett J, Peterson LB, Wicker LS, DeMartino JA
Journal of leukocyte biology 2003 Jun;73(6):771-80

---

Chemokine receptors: signposts to brain development and disease.

Tran PB, Miller RJ
Nature reviews. Neuroscience 2003 Jun;4(6):444-55